Key technology development needs to reduce cost and increase efficiencies of large-scale genome editing, recoding and writing are identified with examples of desired milestones during the next 10 years in the roadmap written and shared in a Science Policy Forum by the Technology and Infrastructure Working Group of the international Genome Project-write (GP-write).  

Some recommendations include improvements to existing technologies; others are newly emerging. The group identified four high-priority areas for development in synthetic genomics: genome design, DNA synthesis, genome editing and chromosome construction.

“Synthetic genomics—the ability to readily design and write the genomes of complex living cells— would provide unique opportunities to gain biological insights and to tackle problems intractable with current technologies. This is particularly true in medicine, where synthetic genomes could be a transformative force to enhance personalized medicine and offer treatments unattainable by standard therapies,” said Ostrov. “For example, genome writing technology could enable low-cost, high-throughput production of advanced CAR T-cells for immunotherapy or be used to encode the production of edible vaccines in common food crops. The same tools could also give us microbes capable of breaking down common plastics into usable chemicals for future bio-recycling facilities, plants capable of producing pharmaceuticals or monitoring air pollution or tissue cultures that are resistant to viruses, radiation, aging or cancer”. 

The group identified four high-priority areas for development in synthetic genomics: genome design, DNA synthesis, genome editing and chromosome construction.

Similar to other large projects such as the Human Genome Project, achieving these advances requires responsible innovation through international, interdisciplinary participation, with funding from governments and the private sector. With such investments, scientists can develop and disseminate new approaches to maximize impact across sectors such as biomedicine, pharmaceuticals, agriculture and the chemical industry. To achieve the potential scientific, social and economic impact, development and adoption of these technologies requires ongoing public discussion of potential pitfalls.

GP-write has organized a federation of interested scientists around the globe who are committed to developing and applying the needed technology. According to one of its co-founders, Jef Boeke, director of the Institute for Systems Genetics at NYU Langone Health, “There is intense interest in reducing barriers to widely deploying this tech, and there is great excitement about big projects like Sc2.0 that can engage a broader community.” 

GP-write has organized a federation of interested scientists around the globe who are committed to developing and applying the needed technology.

Authors of the GP-write Technical and Infrastructure Working Group article appearing in Science include Nili Ostrov, Jacob Beal, Tom Ellis, D. Benjamin Gordon, Bogumil J. Karas, Henry H. Lee, Scott C. Lenaghan, Jeffery A. Schloss, Giovanni Stracquadanio, Axel Trefzer, Joel S. Bader, George M. Church, Cintia M. Coelho, J. William Efcavitch, Marc Güell, Leslie A. Mitchell, Alec A. K. Nielsen, Bill Peck, Alexander C. Smith, C. Neal Stewart Jr. and Hille Tekotte.

More informationat the GP-write website.